Oncolytic Vaccinia Virus Augments T Cell Factor 1-Positive Stem-like CD8<sup>+</sup> T Cells, Which Underlies the Efficacy of Anti-PD-1 Combination Immunotherapy

Oncolytic virotherapy has garnered attention as an antigen-agnostic therapeutic cancer vaccine that induces cancer-specific T cell responses without additional antigen loading. As anticancer immune responses are compromised by a lack of antigenicity and chronic immunosuppressive microenvironments, a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Yun-Hui Jeon, Namhee Lee, Jiyoon Yoo, Solchan Won, Suk-kyung Shin, Kyu-Hwan Kim, Jun-Gyu Park, Min-Gang Kim, Hang-Rae Kim, Keunhee Oh, Dong-Sup Lee
Format: Artigo
Jezik:Inglês
Izdano: MDPI AG 2022-03-01
Serija:Biomedicines
Teme:
oncolytic vaccinia virus
cancer antigen-specific T cells
stem-like CD8<sup>+</sup> T cells
lymphoid organs
immune checkpoint blockade
Online pristup:https://www.mdpi.com/2227-9059/10/4/805
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items